Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy and safety of AnluoHuaxian pills on chronic hepatitis B with normal or minimally elevated alanine transaminase and early liver fibrosis: A randomized controlled trial
Huanming Xiao, Meijie Shi, Junmin Jiang, et al.
Journal of Ethnopharmacology (2022) Vol. 293, pp. 115210-115210
Open Access | Times Cited: 12

Showing 12 citing articles:

Guidelines for the Management of Esophagogastric Variceal Bleeding in Cirrhotic Portal Hypertension
Xiaoyuan Xu, Chengwei Tang, Enqiang Linghu, et al.
Journal of Clinical and Translational Hepatology (2023) Vol. 11, Iss. 7, pp. 1565-1579
Open Access | Times Cited: 14
Integrated UHPLC-Q-Exactive Orbitrap HRMS and Serum Pharmacochemistry for the Investigation of Anti-hepatic Fibrosis Effect of BaoGanNing Decoction
Kaili Deng, Min Li, Liangliang Xiang, et al.
Phytomedicine (2025) Vol. 137, pp. 156363-156363
Closed Access
Chinese Guidelines on the Management of Hepatic Encephalopathy in Cirrhosis (2024)
Xiaoyuan Xu, Huiguo Ding, Wengang Li, et al.
Journal of Clinical and Translational Hepatology (2025) Vol. 000, Iss. 000, pp. 000-000
Open Access
Inflammation-fibrosis interplay in inflammatory bowel disease: mechanisms, progression, and therapeutic strategies
Yanan Li, Feng Xu, Yulai Fang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Traditional Chinese medicine: An important source for discovering candidate agents against hepatic fibrosis
Wenqing Li, Wenhao Liu, Die Qian, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 20
Liver cirrhosis: current status and treatment options using western or traditional Chinese medicine
Shihao Zheng, Chengyuan Xue, Size Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Recent progress on the application of compound formulas of traditional Chinese medicine in clinical trials and basic research in vivo for chronic liver disease
Feipeng Xu, Hua Zhang, Jiamei Chen, et al.
Journal of Ethnopharmacology (2023) Vol. 321, pp. 117514-117514
Closed Access | Times Cited: 7
Hepatitis B: Model Systems and Therapeutic Approaches
Xiaoxiao Yu, Yating Gao, Xin Zhang, et al.
Journal of Immunology Research (2024) Vol. 2024, pp. 1-15
Open Access | Times Cited: 2
Chinese guidelines on the management of ascites in cirrhosis
Xiaoyuan Xu, Huiguo Ding, Jidong Jia, et al.
Hepatology International (2024) Vol. 18, Iss. 4, pp. 1071-1089
Closed Access | Times Cited: 1
Mairin from Huangqi Decoction Mitigates Liver Cirrhosis through Suppression of Pro-inflammatory Signaling Pathways: A Network Pharmacology and Experimental Study
Di Meng, Shuang Ren
The Natural Products Journal (2024) Vol. 14, Iss. 5
Closed Access
The possible pathogenesis of liver fibrosis: therapeutic potential of natural polyphenols
Chengu Niu, Jing Zhang, Patrick Okolo
Pharmacological Reports (2024) Vol. 76, Iss. 5, pp. 944-961
Closed Access
Integrated evidence chain-based effectiveness evaluation of traditional Chinese medicines (iEC-Eff): A demonstration study
Ye Luo, Xu Zhao, Ruilin Wang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 15, Iss. 2, pp. 909-918
Open Access
Page 1

Scroll to top